Hemispherx Biopharma Report issue

For profit Phase 2 Phase 3
Founded: Philadelphia PA United States (1980)

Organization Overview

First Clinical Trial
1997
NCT00215813
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hemispherx Biopharma | HEM Research